Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway

Caveolin 1:PP2A/ATM/p53 通路的新型调节剂

基本信息

项目摘要

DESCRIPTION (provided by applicant): One of the manifestations of aging is the accumulation of damage at both cellular and organism levels. Genotoxic stress plays an important role in aging and age-related diseases such as emphysema, which is caused by a failure of lung maintenance and repair after sustained oxidative stress. Cigarette smoke represents a source of oxidants and is considered an environmental hazard that causes pulmonary emphysema. Premature senescence is believed to contribute to genotoxic stress-induced emphysema. The tumor suppressor protein p53 is a key regulator of premature senescence and is activated by the ataxia-telangiectasia mutated (ATM) protein kinase when the ATM inhibitor protein phosphatase 2A (PP2A) dissociates from ATM after genotoxic stress. The mechanism underlying PP2A-C removal from ATM upon genotoxic stress remains totally unexplored. In addition, the role that the ATM/p53 pathway plays in cigarette smoke-induced cellular senescence and the pathogenesis of emphysema remains largely unknown. Here, we plan to test the hypothesis that the lipid raft protein caveolin-1 mediates stress-induced premature senescence by promoting ATM-dependent activation of p53 through sequestration of the ATM inhibitor PP2A-C into caveolae. In addition, it is hypothesized that caveolin-1 plays a central role in oxidant-promoted emphysema in vivo through induction of cellular senescence. This hypothesis will be tested by pursuing three specific aims: Specific Aim 1: Investigate the role of caveolin-1 in PP2A-mediated regulation of ATM function after genotoxic stress. Specific Aim 2: Determine the functional consequences of loss of caveolin-1 expression on ATM-mediated p53 activation and premature senescence. Specific Aim 3: Define the role of caveolin-1 in genotoxic stress-induced pulmonary emphysema in vivo. These studies will provide novel insights into the signaling machinery that links genotoxic stress to cellular senescence and propose caveolin-1 as a novel therapeutic target for the treatment of age-related diseases such as emphysema. PUBLIC HEALTH RELEVANCE: Oxidative stress, including cigarette smoke, promotes premature cellular senescence, which is believed to have an important role in the more complicated aging process, and contributes to age-related diseases like emphysema. The molecular mechanisms underlying cigarette smoke-induced emphysema are not fully understood. Our studies will test the hypothesis that the protein caveolin-1 is a novel regulator of stress-induced cellular senescence and emphysema, and propose caveolin-1 as an alternative therapeutic target for the treatment of age-related diseases such as emphysema.
描述(由申请人提供):衰老的表现之一是细胞和有机体水平损伤的积累。基因毒性应激在衰老和与年龄相关的疾病(例如肺气肿)中发挥着重要作用,肺气肿是由持续氧化应激后肺部维护和修复失败引起的。香烟烟雾是氧化剂的来源,被认为是导致肺气肿的环境危害。据信过早衰老会导致基因毒性应激诱发的肺气肿。肿瘤抑制蛋白 p53 是过早衰老的关键调节因子,当 ATM 抑制剂蛋白磷酸酶 2A (PP2A) 在基因毒性应激后从 ATM 解离时,它会被共济失调毛细血管扩张突变 (ATM) 蛋白激酶激活。遗传毒性应激时 PP2A-C 从 ATM 中去除的机制尚未完全探索。此外,ATM/p53 通路在香烟烟雾诱导的细胞衰老和肺气肿发病机制中所起的作用仍然很大程度上未知。在这里,我们计划测试以下假设:脂筏蛋白 Caveolin-1 通过将 ATM 抑制剂 PP2A-C 封存在小凹中,促进 ATM 依赖性 p53 激活,从而介导应激诱导的过早衰老。此外,据推测,caveolin-1 通过诱导细胞衰老,在体内氧化剂促进的肺气肿中发挥着核心作用。该假设将通过追求三个具体目标来检验: 具体目标 1:研究 Caveolin-1 在基因毒性应激后 PP2A 介导的 ATM 功能调节中的作用。具体目标 2:确定 Caveolin-1 表达缺失对 ATM 介导的 p53 激活和过早衰老的功能影响。具体目标 3:确定 Caveolin-1 在体内基因毒性应激诱导的肺气肿中的作用。这些研究将为将基因毒性应激与细胞衰老联系起来的信号机制提供新的见解,并提出将caveolin-1作为治疗肺气肿等年龄相关疾病的新治疗靶点。公共健康相关性:包括香烟烟雾在内的氧化应激会促进细胞过早衰老,这被认为在更复杂的衰老过程中发挥着重要作用,并导致肺气肿等与年龄相关的疾病。香烟烟雾诱发肺气肿的分子机制尚不完全清楚。我们的研究将检验这一假设,即蛋白质 Caveolin-1 是应激诱导的细胞衰老和肺气肿的新型调节剂,并提出 Caveolin-1 作为治疗肺气肿等年龄相关疾病的替代治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FERRUCCIO GALBIATI其他文献

FERRUCCIO GALBIATI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FERRUCCIO GALBIATI', 18)}}的其他基金

Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9899946
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9459856
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9305499
  • 财政年份:
    2017
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    9059176
  • 财政年份:
    2015
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    9279206
  • 财政年份:
    2015
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    8903586
  • 财政年份:
    2014
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8114097
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8507585
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8301580
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    7574065
  • 财政年份:
    2009
  • 资助金额:
    $ 30.25万
  • 项目类别:

相似国自然基金

TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
  • 批准号:
    82220108016
  • 批准年份:
    2022
  • 资助金额:
    252 万元
  • 项目类别:
    国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81800806
  • 批准年份:
    2018
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81700824
  • 批准年份:
    2017
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
  • 批准号:
    81670269
  • 批准年份:
    2016
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
A2E老化ARMS2/HTRA1型iPSC-RPE细胞的研究:个体化AMD发病机制初步探索
  • 批准号:
    81400412
  • 批准年份:
    2014
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 30.25万
  • 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 30.25万
  • 项目类别:
Core B: Biospecimen Core
核心 B:生物样本核心
  • 批准号:
    10555894
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
  • 批准号:
    10555899
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
  • 批准号:
    10556087
  • 财政年份:
    2023
  • 资助金额:
    $ 30.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了